Ignite Creation Date:
2024-05-06 @ 12:08 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01499251
Status:
TERMINATED
Last Update Posted:
2016-05-05
First Post:
2011-12-20
Brief Title:
Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Sponsor:
Actelion
Organization:
Actelion
Organization Data
Organization:
Actelion
Class:
INDUSTRY
Study ID:
AC-055-115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Actelion
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None